日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

对放射性碘治疗有特殊反应的转移性甲状腺癌的基因组和转录组特征

Laura Boucai #, Mahesh Saqcena #, Fengshen Kuo, Ravinder K Grewal, Nicholas Socci, Jeffrey A Knauf, Gnana P Krishnamoorthy, Mabel Ryder, Alan L Ho, Ronald A Ghossein, Luc G T Morris, Venkatraman Seshan, James A Fagin

Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors

根据免疫特征对患者进行分类:一种识别对检查点抑制剂有反应的候选者的新方法

Svetlana Bornschlegl, Michael P Gustafson, Danae A Delivanis, Mabel Ryder, Minetta C Liu, George Vasmatzis, Chris L Hallemeier, Sean S Park, Lewis R Roberts, Ian F Parney, Diane F Jelinek, Allan B Dietz0

Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations

免疫检查点抑制剂诱发的甲状腺炎与甲状腺内 T 淋巴细胞亚群增加有关

Anupam Kotwal, Michael P Gustafson, Svetlana Bornschlegl, Lisa Kottschade, Danae A Delivanis, Allan B Dietz, Manish Gandhi, Mabel Ryder

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

患者匹配的甲状腺细胞系和患者来源的肿瘤异种移植的方法、标准和特征

Laura A Marlow, Stephen D Rohl, James L Miller, Jeffery A Knauf, James A Fagin, Mabel Ryder, Dragana Milosevic, Brian C Netzel, Stefan K Grebe, Honey V Reddi, Robert C Smallridge, John A Copland

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene

转座子诱变鉴定出在甲状腺肿瘤发生中与 Ras 合作的染色质修饰物,并检测出 ATXN7 是一种癌症基因

Cristina Montero-Conde, Luis J Leandro-Garcia, Xu Chen, Gisele Oler, Sergio Ruiz-Llorente, Mabel Ryder, Iñigo Landa, Francisco Sanchez-Vega, Konnor La, Ronald A Ghossein, Dean F Bajorin, Jeffrey A Knauf, Jesse D Riordan, Adam J Dupuy, James A Fagin

Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas

RAF 和 MEK 抑制剂缓解 HER3 转录的反馈抑制会减弱其在 BRAF 突变型甲状腺癌中的抗肿瘤作用

Cristina Montero-Conde, Sergio Ruiz-Llorente, Jose M Dominguez, Jeffrey A Knauf, Agnes Viale, Eric J Sherman, Mabel Ryder, Ronald A Ghossein, Neal Rosen, James A Fagin

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells

靶向 RET 突变髓样和分化型甲状腺癌细胞中的 mTOR

Matti L Gild, Iñigo Landa, Mabel Ryder, Ronald A Ghossein, Jeffrey A Knauf, James A Fagin

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

小分子 MAPK 抑制剂通过条件性 BRAF 激活恢复小鼠甲状腺癌中的放射性碘掺入

Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A Knauf, Xiao-Hui Liao, Brian L West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M Larson, Samuel Refetoff, Ronald Ghossein, James A Fagin